NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 1 filers reported holding NURIX THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $284,000 | -66.9% | 36,138 | -58.0% | 0.00% | -66.7% |
| Q2 2023 | $859,000 | +5.8% | 85,986 | -6.0% | 0.00% | 0.0% |
| Q1 2023 | $812,000 | -11.6% | 91,479 | +9.3% | 0.00% | -25.0% |
| Q4 2022 | $919,000 | -5.6% | 83,715 | +12.0% | 0.00% | 0.0% |
| Q3 2022 | $974,000 | +31.1% | 74,739 | +27.4% | 0.00% | +33.3% |
| Q2 2022 | $743,000 | +23.4% | 58,652 | +36.5% | 0.00% | +50.0% |
| Q1 2022 | $602,000 | -27.7% | 42,955 | +49.2% | 0.00% | -33.3% |
| Q4 2021 | $833,000 | -3.5% | 28,791 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $863,000 | +13.0% | 28,791 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $764,000 | -14.6% | 28,791 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $895,000 | – | 28,791 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi II Management, LLC | 561,574 | $16,825,000 | 24.93% |
| Ponoi Management, LLC | 561,573 | $16,825,000 | 14.94% |
| TRV GP III, LLC | 2,422,549 | $72,580,000 | 13.78% |
| Foresite Capital Management IV, LLC | 1,205,798 | $36,126,000 | 5.32% |
| Foresite Capital Management V, LLC | 451,522 | $13,528,000 | 4.20% |
| WestHill Financial Advisors, Inc. | 283,333 | $8,489,000 | 2.62% |
| DAFNA Capital Management LLC | 306,320 | $9,177,000 | 2.44% |
| Bain Capital Life Sciences Investors, LLC | 1,284,314 | $38,478,000 | 2.39% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 571,212 | $17,113,000 | 2.02% |
| Redmile Group, LLC | 3,093,077 | $92,669,000 | 1.62% |